These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 20549695)
1. Use of drug-eluting stents for chronic total occlusions: a systematic review and meta-analysis. Saeed B; Kandzari DE; Agostoni P; Lombardi WL; Rangan BV; Banerjee S; Brilakis ES Catheter Cardiovasc Interv; 2011 Feb; 77(3):315-32. PubMed ID: 20549695 [TBL] [Abstract][Full Text] [Related]
2. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries. Wöhrle J; Werner GS Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572 [TBL] [Abstract][Full Text] [Related]
3. Five-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) Registry. Shen ZJ; García-García HM; Garg S; Onuma Y; Schenkeveld L; van Domburg RT; Serruys PW; Catheter Cardiovasc Interv; 2009 Dec; 74(7):979-86. PubMed ID: 19753636 [TBL] [Abstract][Full Text] [Related]
4. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial. Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607 [TBL] [Abstract][Full Text] [Related]
5. 3-year clinical outcome of patients with chronic total occlusion treated with drug-eluting stents. De Felice F; Fiorilli R; Parma A; Nazzaro M; Musto C; Sbraga F; Caferri G; Violini R JACC Cardiovasc Interv; 2009 Dec; 2(12):1260-5. PubMed ID: 20129553 [TBL] [Abstract][Full Text] [Related]
6. Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial. Lemos PA; Moulin B; Perin MA; Oliveira LA; Arruda JA; Lima VC; Lima AA; Caramori PR; Medeiros CR; Barbosa MR; Brito FS; Ribeiro EE; Martinez EE; Catheter Cardiovasc Interv; 2009 Nov; 74(5):665-73. PubMed ID: 19670303 [TBL] [Abstract][Full Text] [Related]
7. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries. Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW; JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464 [TBL] [Abstract][Full Text] [Related]
8. Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice. Appleby CE; Khattar RS; Morgan K; Clarke B; Curzen N; Neyses L; Fath-Ordoubadi F EuroIntervention; 2011 Jan; 6(6):748-53. PubMed ID: 21205600 [TBL] [Abstract][Full Text] [Related]
9. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY). Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G; JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420 [TBL] [Abstract][Full Text] [Related]
10. Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program. Stone GW; Ellis SG; Colombo A; Grube E; Popma JJ; Uchida T; Bleuit JS; Dawkins KD; Russell ME JACC Cardiovasc Interv; 2011 May; 4(5):530-42. PubMed ID: 21596326 [TBL] [Abstract][Full Text] [Related]
11. Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. Stefanini GG; Kalesan B; Pilgrim T; Räber L; Onuma Y; Silber S; Serruys PW; Meier B; Jüni P; Windecker S JACC Cardiovasc Interv; 2012 Mar; 5(3):301-10. PubMed ID: 22440496 [TBL] [Abstract][Full Text] [Related]
12. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials. Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419 [TBL] [Abstract][Full Text] [Related]
13. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials. Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661 [TBL] [Abstract][Full Text] [Related]
14. Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents. Kandzari DE; Leon MB; Meredith I; Fajadet J; Wijns W; Mauri L JACC Cardiovasc Interv; 2013 May; 6(5):504-12. PubMed ID: 23602459 [TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of the efficacy and safety of zotarolimus-eluting stents vs. sirolimus-eluting stents for percutaneous coronary intervention in chronic total occlusion--CAtholic Total Occlusion Study (CATOS) trial. Park HJ; Kim HY; Lee JM; Choi YS; Park CS; Kim DB; Her SH; Koh YS; Park MW; Kwon BJ; Kim PJ; Chang K; Chung WS; Seung KB Circ J; 2012; 76(4):868-75. PubMed ID: 22277317 [TBL] [Abstract][Full Text] [Related]
16. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial. Di Lorenzo E; De Luca G; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G JACC Cardiovasc Interv; 2009 Jun; 2(6):515-23. PubMed ID: 19539255 [TBL] [Abstract][Full Text] [Related]
18. Acute and long-term outcomes of ostial stentings among bare-metal stents, sirolimus-eluting stents, and paclitaxel-eluting stents. Hsieh IC; Hsieh MJ; Chang SH; Wang CY; Lee CH; Lin FC; Chen CC Coron Artery Dis; 2013 May; 24(3):224-30. PubMed ID: 23571311 [TBL] [Abstract][Full Text] [Related]
19. Angiographic and clinical outcomes of drug-eluting versus bare metal stent deployment in the Occluded Artery Trial. Dzavík V; Buller CE; Devlin G; Carere RG; Mancini GB; Cantor WJ; Buszman PE; Rankin JM; Vozzi C; Ross JR; Forman S; Barton BA; Lamas AG; Hochman JS Catheter Cardiovasc Interv; 2009 May; 73(6):771-9. PubMed ID: 19309733 [TBL] [Abstract][Full Text] [Related]
20. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]